Global Kidney Function Test Market Overview
As per MRFR analysis, the Kidney Function Test Market Size was estimated at 2.04 (USD Billion) in 2023. The Kidney Function Test Market Industry is expected to grow from 2.13(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The Kidney Function Test Market CAGR (growth rate) is expected to be around 4.62% during the forecast period (2025 - 2035)
Key Kidney Function Test Market Trends Highlighted
The Kidney Function Test Market is currently undergoing substantial trends that are indicative of the growing emphasis on preventive healthcare and the necessity of early detection of kidney-related issues. The increasing prevalence of chronic kidney disease (CKD) among a variety of demographics is one of the primary market drivers. Healthcare systems worldwide are compelled to prioritize renal health due to the increased prevalence of factors such as diabetes, hypertension, and an aging population. The increasing awareness of renal health further exacerbates this trend, as educational campaigns emphasize the significance of routine kidney function testing. Additionally, opportunities are emerging in the Kidney Function Test Market as a result of advancements in diagnostic technologies.
The accessibility and user-friendliness of kidney function tests are being enhanced by innovations such as point-of-care testing and the development of non-invasive testing methodologies. Healthcare providers have the opportunity to enhance patient outcomes and broaden their offerings as a result of this transition to more efficient testing options. In recent years, there has been a discernible trend toward the integration of artificial intelligence and machine learning into kidney function testing. These technologies are improving the precision of diagnoses and the ability to foretell patient outcomes more effectively. The significance of data-driven decision-making is also underscored by global healthcare policies, which promote the implementation of technology-driven solutions in medical testing.
In general, the Kidney Function Test Market is undergoing a rapid transformation, which is influenced by the interplay of increasing disease prevalence, technological advancements, and a continuous effort to improve healthcare practices. Organizations and healthcare providers are encouraged to capitalize on these trends by proactively addressing kidney health and investigating novel methods to more effectively engage and reach patients.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Kidney Function Test Market Drivers
Increasing Prevalence of Chronic Kidney Disease
The Kidney Function Test Market Industry is experiencing growth due to the rising prevalence of chronic kidney disease (CKD), which affects approximately 13% of the global population according to the Global Health Observatory. Given this significant statistic, approximately 850 million people globally suffer from kidney diseases. Reports from entities like the World Health Organization highlight that CKD is becoming a leading cause of morbidity and mortality worldwide.
The increasing awareness and diagnosis of kidney-related ailments compel healthcare systems to invest in kidney function testing, thereby driving the demand for testing products and services in the Kidney Function Test Market. As more clinics and hospitals integrate kidney function tests into routine check-ups, industry players can expect consistent growth and advancements in testing technologies.
Technological Advancements in Testing Methods
Innovations in testing technology significantly contribute to the growth of the Kidney Function Test Market. Advanced diagnostic methods, such as novel biomarkers and point-of-care testing devices, are enhancing the accuracy and efficiency of kidney function assessments. For instance, the development of non-invasive tests like the estimated glomerular filtration rate (eGFR) has improved diagnostic capabilities. According to the National Institute of Diabetes and Digestive and Kidney Diseases, the use of advanced testing technologies could lead to a reduction of up to 30% in misdiagnosis rates.
Prominent companies, such as Siemens Healthineers and Abbott Laboratories, are continuously investing in Research and Development (R&D) to innovate these technologies and respond to the demand for faster and more precise testing solutions.
Rising Awareness and Preventive Health Measures
Growing global awareness about kidney health is a crucial driver for the Kidney Function Test Market Industry. Campaigns about the importance of kidney function tests are increasing, particularly among high-risk populations. For instance, the Kidney Foundation's campaigns have raised awareness in the general population about the symptoms and risks associated with kidney diseases, consequently prompting more individuals to pursue testing as a preventive measure.
This heightened awareness is evident in the increase of routine check-ups and screenings conducted in various healthcare institutions, which has been noted to increase by approximately 20% in the last five years, according to statistics from the Centers for Disease Control and Prevention. As healthcare providers expand their outreach programs, the demand for kidney function testing is expected to rise, leading to considerable market growth.
Kidney Function Test Market Segment Insights
Kidney Function Test Market Test Type Insights
The Kidney Function Test Market is categorized into various test types that play crucial roles in assessing kidney health, with significant valuations highlighting their importance. In 2024, the Blood Tests segment is projected to be valued at 0.76 USD billion, whereas it is expected to reach 1.24 USD billion by 2035, showcasing a robust demand for this type of testing. Blood Tests are essential as they provide critical information about kidney function by measuring waste levels and other important biomarkers in the blood, which is vital for early detection and disease management.
Following this, the Urine Tests segment is anticipated to register a value of 0.52 USD billion in 2024, growing to 0.85 USD billion in 2035. Urine Tests are significant due to their non-invasive nature and their ability to measure various substances excreted by the kidneys, which aids in diagnosing kidney abnormalities and monitoring underlying conditions. The Imaging Tests segment, valued at 0.38 USD Billion in 2024 and projected to grow to 0.6 USD Billion by 2035, encompasses essential diagnostic techniques like ultrasound and CT scans that help visualize kidney structures and identify any obstructions or anomalies.
This aspect of testing contributes to the overall kidney function assessment by providing visual evidence of physical conditions affecting kidney health. Finally, the Biopsy Procedures segment is expected to be valued at 0.47 USD billion in 2024, with an increase to 0.71 USD billion in 2035. This segment holds significance as it involves directly examining kidney tissue to obtain a definitive diagnosis, making it a crucial method when less invasive tests yield inconclusive results. Collectively, these test types encapsulate the breadth of diagnostic capabilities available in the Kidney Function Test Market, driving growth and providing critical insights into public health as healthcare systems continue to prioritize early detection and management of kidney diseases.
The market growth is likely propelled by rising incidences of kidney-related disorders globally, along with increasing health awareness and advancements in diagnostic technologies.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Kidney Function Test Market End User Insights
The Kidney Function Test Market is witnessing significant growth driven by various end-user applications, including Hospitals, Diagnostic Laboratories, Home Care Settings, and Ambulatory Surgical Centers. In 2024, the total market is expected to reach a valuation of 2.13 billion USD, reflecting the ongoing demand for effective renal diagnostics and monitoring. Hospitals are a critical sector, as they provide comprehensive care for patients with chronic kidney disease, illustrating their importance in early detection and management. Diagnostic Laboratories are also essential, serving as the backbone for accurate test results and advanced technologies.
Furthermore, Home Care Settings are gaining traction, allowing patients to undergo kidney function tests in the comfort of their homes, which meets the rising preference for at-home healthcare solutions. Ambulatory Surgical Centers play a significant role as well, facilitating timely interventions and follow-ups for patients requiring immediate attention. The growing prevalence of kidney disorders and increasing awareness of renal health are key drivers fueling the Kidney Function Test Market, creating ample opportunities for all these end-user segments to thrive.
Kidney Function Test Market Test Parameters Insights
The Kidney Function Test Market is projected to reach a valuation of 2.13 USD billion in 2024, highlighting the critical role of Test Parameters in evaluating renal health. Among these parameters, Glomerular Filtration Rate (GFR) is crucial as it assesses kidney filtering performance, providing vital insights into kidney function and health. Serum Creatinine Levels are also significant, serving as a key indicator of kidney function and potential disease progression. Urine Protein Levels offer valuable information about kidney damage or disease, while Electrolyte Levels are essential for monitoring the balance of minerals crucial for bodily functions.
Notably, the demand for these tests is propelled by rising kidney diseases and increasing awareness about regular health check-ups; moreover, adherence to health guidelines and the introduction of advanced diagnostic technologies present opportunities for market expansion. The Kidney Function Test Market data supports that these Test Parameters not only aid in disease diagnosis but also in effective management, contributing significantly to the overall market growth.
Kidney Function Test Market Application Insights
The Kidney Function Test Market, particularly focusing on the Application segment, presents a noteworthy landscape characterized by the need for efficient diagnostics and management strategies. The market is projected to reach a valuation of approximately 2.13 USD billion by 2024, reflecting an increasing commitment to kidney health. Key applications, including Chronic Kidney Disease and Acute Kidney Injury, are significant due to the rising prevalence of these conditions on a global scale. Diabetes Management also plays a crucial role, given the strong correlation between diabetes and kidney disorders.
Similarly, the importance of Hypertension Management cannot be understated, as high blood pressure is a leading risk factor for kidney impairment. These applications dominate the market by addressing urgent health needs and facilitating early intervention, which is essential for improving patient outcomes. The Kidney Function Test Market segmentation further highlights an evolving landscape that is driven by the necessity for comprehensive and targeted health solutions, capturing the attention of healthcare professionals and policymakers alike.
As healthcare systems globally evolve, the demand for innovation in these application areas is anticipated to grow steadily, aligning with market trends and growth drivers focused on enhancing patient care and managing chronic diseases effectively.
Kidney Function Test Market Regional Insights
The Kidney Function Test Market, valued at 2.13 USD billion in 2024, showcases diverse dynamics across various regions. North America leads with a substantial contribution, holding a valuation of 0.85 USD billion in 2024 and showing significant growth to 1.3 USD billion by 2035, reflecting its majority holding in market share, driven by advanced healthcare infrastructure and increased awareness of kidney diseases. Europe follows with a valuation of 0.6 USD Billion in 2024, projected to reach 0.95 USD billion by 2035, supported by stringent regulations and a rising prevalence of chronic kidney conditions.
South America, with a valuation of 0.2 USD Billion in 2024, increasing to 0.3 USD Billion in 2035, shows steady growth, driven by improving healthcare access and economic development. The Asia Pacific region is anticipated to grow significantly, valued at 0.4 USD Billion in 2024 and reaching 0.75 USD billion by 2035, fueled by rising population awareness and healthcare investments. The Middle East and Africa, though representing the smallest share with 0.08 USD billion in 2024, are gradually gaining traction due to increasing healthcare initiatives and rising patient populations.
Overall, the Kidney Function Test Market segmentation reveals a clear trajectory of growth and potential across all regions, driven by healthcare advancements and the pressing need for effective kidney disease management.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Kidney Function Test Market Key Players and Competitive Insights
The Kidney Function Test Market is characterized by a dynamic competitive landscape that evolves with advancements in medical technology and growing awareness surrounding kidney health. As kidney diseases become increasingly prevalent across the globe, the demand for accurate and efficient testing solutions has risen significantly. Numerous innovative firms are entering the market with diagnostic tests that cater to the need for early detection and management of renal ailments. The competition is not only driven by technological advancements but also by strategic collaborations, mergers, and partnerships among established companies and biotech startups aiming to develop cutting-edge solutions for kidney function assessment. Understanding the competitive landscape within the Kidney Function Test Market is crucial for stakeholders to identify emerging trends, potential threats, and opportunities for growth.
F. Hoffmann-La Roche is a key player in the Kidney Function Test Market, known for its commitment to providing advanced diagnostic solutions. The company's strong market presence is characterized by a diversified portfolio of high-quality products that focus on renal health. F. Hoffmann-La Roche has distinguished itself through innovations that enhance the accuracy and reliability of kidney function assessments, leveraging its extensive expertise in biochemistry and molecular diagnostics. The company is also recognized for its robust research and development capabilities, which allow it to stay ahead of competitors by introducing state-of-the-art testing methodologies. Furthermore, its widespread distribution networks and collaborative initiatives with healthcare providers bolster its position in the market, ensuring that its testing solutions are accessible to a wide range of clinicians and patients around the globe.
Thermo Fisher Scientific has a significant impact on the kidney function test market by providing advanced diagnostic platforms, reagents, and lab services. The company is recognized for providing dependable, high-quality solutions that facilitate the identification and ongoing monitoring of kidney function disorders. The company's portfolio comprises immunoassays and clinical chemistry reagents for critical biomarkers, including creatinine, cystatin C, and urea, which are indispensable for the diagnosis of renal health issues. Automated analyzers from Thermo Fisher optimize laboratory workflows, guaranteeing rapid and precise outcomes. In addition, the company's integration of digital data management tools with diagnostics facilitates clinical decision-making and improves patient care. Among laboratories and healthcare providers worldwide, Thermo Fisher maintains its reputation as a trusted name in kidney diagnostics by prioritizing precision, innovation, and clinical relevance.
Key Companies in the Kidney Function Test Market Include
- Hoffmann-La Roche
- Quest Diagnostics
- Bio-Rad Laboratories
- Arkray
- Thermo Fisher Scientific
- Siemens Healthineers
- Roche Diagnostics
- Laboratory Corporation of America
- Danaher Corporation
- Alere
- DiaSorin
- Ortho Clinical Diagnostics
- Abbott Laboratories
Kidney Function Test Market Industry Developments
In recent months, the Kidney Function Test Market has seen significant developments, particularly focusing on the advancements and collaborations among key players.
In January 2025, the MediBeacon® Transdermal GFR System (TGFR) from INNOVATE Corp was granted FDA approval for the non-invasive, point-of-care evaluation of kidney function. This system utilizes the Lumitrace® fluorescent tracer and skin sensor to provide real-time GFR readings without the need for blood draws or urine tests.
In March 2025, MediBeacon's TGFR Monitor and Sensor were approved by China's NMPA, thereby extending regulatory authorization for non-invasive GFR monitoring into the Chinese market.
In September 2024,  Travere Therapeutics announced the FDA's acceptance of a supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis (FSGS). The drug is already approved for the purpose of reducing the decline in kidney function in patients with IgA nephropathy.
Overall, as the demand for better diagnostics and treatment reliability increases, companies like Thermo Fisher Scientific, Laboratory Corporation of America, and Abbott Laboratories are poised to benefit from these trends.
Kidney Function Test Market Segmentation Insights
Kidney Function Test Market Test Type Outlook
- Blood Tests
- Urine Tests
- Imaging Tests
- Biopsy Procedures
Kidney Function Test Market End User Outlook
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Ambulatory Surgical Centers
Kidney Function Test Market Test Parameters Outlook
- Glomerular Filtration Rate
- Serum Creatinine Levels
- Urine Protein Levels
- Electrolyte Levels
Kidney Function Test Market Application Outlook
- Chronic Kidney Disease
- Acute Kidney Injury
- Diabetes Management
- Hypertension Management
Kidney Function Test Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
|
Report Attribute/Metric
|
Details
|
|
Market Size 2023
|
2.04(USD Billion)
|
|
Market Size 2024
|
2.13(USD Billion)
|
|
Market Size 2035
|
3.5(USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
4.62% (2025 - 2035)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025 - 2035
|
|
Historical Data
|
2019 - 2024
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
F. Hoffmann-La Roche, Bayer AG, Quest Diagnostics, BioRad Laboratories, Arkray, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, Laboratory Corporation of America, Danaher Corporation, Alere, DiaSorin, Ortho Clinical Diagnostics, Abbott Laboratories, Merck KGaA
|
|
Segments Covered
|
Test Type, End User, Test Parameters, Application, Regional
|
|
Key Market Opportunities
|
Rising prevalence of kidney diseases, Increasing demand for home testing, Advancements in diagnostic technology, Growing awareness of kidney health, Expansion of healthcare infrastructure
|
|
Key Market Dynamics
|
Increasing prevalence of kidney diseases, Growing demand for early diagnosis, Advancement in diagnostic technologies, Rising geriatric population, Expanding healthcare expenditure
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Frequently Asked Questions (FAQ) :
The Kidney Function Test Market is expected to be valued at approximately 2.13 USD Billion in 2024.
By 2035, the Kidney Function Test Market is anticipated to reach a valuation of around 3.5 USD billion.
The expected compound annual growth rate (CAGR) for the Kidney Function Test Market is 4.62% from 2025 to 2035.
In 2024, North America is expected to hold the largest share of the Kidney Function Test Market, valued at approximately 0.85 USD billion.
The estimated market value of the Kidney Function Test Market in Europe by 2035 is around 0.95 USD billion.
Major players in the Kidney Function Test Market include F. Hoffmann-La Roche, Bayer AG, and Quest Diagnostics, among others.
By 2035, the market value for Blood Tests in the Kidney Function Test Market is expected to reach approximately 1.24 USD billion.
The market value for Urine Tests is expected to be 0.52 USD billion in 2024 and rise to 0.85 USD billion by 2035.
The market value for Imaging Tests is projected to increase from 0.38 USD billion in 2024 to approximately 0.6 USD billion by 2035.
The Asia Pacific region is expected to grow, with the market value anticipated to increase from 0.4 USD Billion in 2024 to approximately 0.75 USD billion by 2035.
